Interleukin-2 (IL2)

Open studies are marked with a purple background, closed studies have a grey background, studies to be opened have a white background
30012
A Randomised Controlled Trial of Interferon-alpha, Interleukin-2 and 5-Fluorouracil vs Interferon-alpha Alone in Patients with Advanced Renal Cell Carcinoma.
06991
The value of high dose versus standard dose Ara-c during induction and IL-2 after intensive consolidation/autologous stem cell transplantation in patients (age 15-60 yrs) with acute myelogenous leukemia. A randomized phase III trial of the EORTC and GIMEMA Leukemia Cooperative Groups (AML-12).

Back to Protocol section